Search results for "Recent Research"


 
Results 1 - 10 of about 347 for "Recent Research".
Sort by: Relevance | Newest | Oldest

Tackling ED boarding

Hospitalists can take ownership to reduce risks for patients, especially elderly ones.
https://acphospitalist.acponline.org/archives/2024/02/21/tackling-ed-boarding.htm
21 Feb 2024

Buprenorphine, cannabis, and other periop challenges

Perioperative medication management is particularly tricky when it comes to patients who are already taking drugs for chronic pain.
https://acphospitalist.acponline.org/archives/2023/11/22/buprenorphine-cannabis-and-other-periop-challenges.htm
22 Nov 2023

Catheter-directed thrombolysis reduced mortality versus anticoagulation alone in PE

For patients with acute pulmonary embolism, including those at intermediate risk, anticoagulation carried a lower risk of major bleeding than catheter-directed or systemic thrombolysis, a recent review also found.
https://acphospitalist.acponline.org/archives/2023/10/25/catheter-directed-thrombolysis-reduced-mortality-versus-anticoagulation-alone-in-pe.htm
25 Oct 2023

Adding up adverse events

Patient safety experts talk about the latest data and what hospitalists can do to improve them.
https://acphospitalist.acponline.org/archives/2023/06/07/adding-up-adverse-events.htm
7 Jun 2023

Studies estimate risks of bleeding, death in patients with cancer and atrial fibrillation

One recent study compared the predictive value of the HAS-BLED, ATRIA, and ORBIT scores in patients with cancer and afib, while another looked at clot, bleeding, and mortality risk with warfarin versus a direct-acting oral anticoagulant in patients with both conditions.
https://acphospitalist.acponline.org/archives/2022/12/07/studies-estimate-risks-of-bleeding-death-in-patients-with-cancer-and-atrial-fibrillation.htm
7 Dec 2022

COVID-19 guideline update from NIH, postdischarge anticoagulation, remdesivir effects

The latest news on inpatient COVID-19 care includes some changes to the NIH guidelines for COVID-19 treatment, as well as studies showing that rivaroxaban after discharge reduced clots and remdesivir helped inpatients on no or low-flow oxygen but not those who were sicker.
https://acphospitalist.acponline.org/weekly/archives/2021/12/22/1.htm
22 Dec 2021

Combating clots in COVID-19

Critical care experts advised on appropriate prophylaxis for ward and ICU patients as part of the CHEST 2021 conference.
https://acphospitalist.acponline.org/archives/2021/11/combating-clots-in-covid-19.htm
15 Nov 2021

Heparin dosing for COVID-19 inpatients, expert perspectives on boosters

Two new trials offered some support for therapeutic anticoagulation in inpatients with elevated d-dimer levels. Antithrombotic therapy didn't prove helpful for outpatients with COVID-19. FDA advisors, an ACP/Annals forum, and recent research addressed vaccine effectiveness and boosters.
https://acphospitalist.acponline.org/weekly/archives/2021/10/20/1.htm
20 Oct 2021

Dexamethasone use, pandemic cardiac arrests and HAIs, latest COVID-19 vaccine news

Recent studies looked at use of dexamethasone and rates of in-hospital cardiac arrest in COVID-19 patients, hospital-acquired infections (HAIs) during the pandemic, and vaccine-induced immune thrombocytopenia. Also, the FDA and new research supported a third vaccine dose for organ transplant patients.
https://acphospitalist.acponline.org/weekly/archives/2021/08/18/1.htm
18 Aug 2021

Good news on IL-6 inhibitors for COVID-19, bad news on other drugs, effects of surge

The NIH updated its guidelines; recent research looked at interleukin-6 (IL-6) inhibitors, ivermectin, remdesivir, and hydroxychloroquine in COVID-19; and one study estimated that 23.2% of inpatient COVID-19 deaths last spring and summer could relate to hospital strain.
https://acphospitalist.acponline.org/weekly/archives/2021/07/14/1.htm
14 Jul 2021

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next